Generic Name and Formulations:
Ciprofloxacin 0.3%, fluocinolone acetonide 0.025%; otic soln; preservative-free.
Arbor Pharmaceuticals, LLC
Indications for OTOVEL:
Acute otitis media in pediatric patients with tympanostomy tubes due to S. aureus, S. pneumoniae, H. influenzae, M. catarrhalis, P. aeruginosa.
Adults and Children:
<6 months: not studied. ≥6 months: 1 vial (0.25mL) into affected ear(s) twice daily for 7 days.
Viral otic infections (eg, varicella, herpes simplex, fungal).
Discontinue if superinfection or hypersensitivity occurs. Reevaluate if no improvement after 1 week or if ≥2 episodes occur within 6 months. Pregnancy. Nursing mothers.
Antibiotic (quinolone) + steroid.
Otorrhea, excessive granulation tissue, ear infection, ear pruritus, tympanic membrane disorder, auricular swelling, balance disorder.
Single-dose vials (0.25mL)—14
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- A Ketogenic Diet as an Adjunct to Cancer Treatment
- Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves
- Blinatumomab-Ponatinib Salvage Therapy in B-Cell Acute Lymphoblastic Leukemia: Case Report of Benefit
- FDA Provides Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- Nivolumab-Ipilimumab Survival Benefit in Advanced RCC Confirmed
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Adding Chemotherapy to Radiation Post-Radical Cystectomy Improves Survival in Urothelial Carcinoma
- Radiation, Chemotherapy Not Beneficial in Localized Upper Tract Urothelial Carcinoma
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer